هل تؤثر الأمراض الغددية ذات الصلة بمثبطات نقاط التفتيش المناعية على معدلات البقاء للمرضى المصابين بالسرطان؟ عرض حالتين

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Patient with immune checkpoint inhibitor Pembrolizumab associated endocrine dysfunctions: a report of clinical case2024
2. 2Endocrine toxicity is an independent predictor of survival in lung cancer patients treated with immune checkpoint inhibitors2024
3. 3Immunotherapy induced endocrinopathies2024
4. 4Emerging endocrine complications in cancer immunotherapy2024
5. 5Combined endocrine-related adverse effects of immune checkpoint inhibitors in a male patient with advanced cutaneous melanoma and multiple co-morbidities2024